Irreversible HER2 inhibitors overcome resistance to the RSL3 ferroptosis inducer in non-HER2 amplified luminal breast cancer
Soon Young Park(Oregon Health & Science University), Gordon B. Mills(The University of Texas MD Anderson Cancer Center)
Cited by 44
Related Papers
AACR Project GENIE: Powering Precision Medicine through an International Consortium
|Cancer Discovery|2017|2k
Rethinking ovarian cancer: recommendations for improving outcomes
|Nature reviews. Cancer|2011|1.5k
The chromatin accessibility landscape of primary human cancers
|Science|2018|1.3k